UnitedHealth Group (UNH) is listed among the 7 Best Fortune 500 Dividend Stocks to Invest in Now. The company is focusing on operational changes following external audits conducted by outside consulting firms. CEO Stephen Hemsley pledged to review the business after missing profit forecasts due to government reimbursement rates and patient mix issues.

UnitedHealth Group (UNH) operates clinical services through Optum Health, OptumRx pharmacy benefit manager, and UnitedHealthcare insurance arm. A review found some lack of standardized documentation, particularly in the in-home health assessment program. The company faces scrutiny over payments from Medicare Advantage plans and is cooperating with Justice Department investigations.

An Analysis Group report suggested that OptumRx could benefit from more standardized audit practices and increased automation. Despite UNH’s potential as an investment, some believe other AI stocks offer greater upside and less risk. Investors can explore undervalued AI stocks in a free report for better investment opportunities.

This news highlights the importance of operational changes at UnitedHealth Group (UNH) following audits, potential investment opportunities, and ongoing scrutiny over Medicare Advantage payments. Stay informed about the evolving landscape of healthcare services and insurance industries for potential market insights.

Read more at Yahoo Finance: UnitedHealth Group (UNH) Prepares for Operational Changes Following External Audit